AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Sulnox Group PLC

Transaction in Own Shares Apr 4, 2023

10293_rns_2023-04-04_d4be5287-8b78-47f4-ad27-f7c1b7cfbff5.html

Transaction in Own Shares

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 3263V

SulNOx Group PLC

04 April 2023

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION 11 OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310

4 April 2023

SulNOx Group Plc (the "Company" or "SulNOx")

Option Agreements

(Aquis Stock Exchange: SNOX)

The board of the directors of the Company (the "Board") has been informed that several shareholders are entering into option agreements (the "Option Agreements") in respect of the Company's ordinary shares of 2 pence each ("Ordinary Shares").  The Option Agreements are being entered into with a single counterparty, RemNOx Ltd. ("RemNOx"), who hold 6,060,000 Ordinary Shares, equating to 6.00% of the Ordinary Shares.  RemNOx is a distributor of the SulNOxEco fuel conditioner products.

The Option Agreements give RemNOx the option to purchase a total of 24,000,000 Ordinary Shares at a price of 30 pence per Ordinary Share between 31 March 2023 and 29 September 2023 (unless extended by mutual agreement).  If fully exercised, this would result in RemNOx owning approximately 29.78 per cent of the Company's issued Ordinary Shares (including RemNOx's exiting holding).  No premiums were paid under the Option Agreements. 

Under the Option Agreements, the voting rights of the Ordinary Shares subject to the options have been transferred to RemNOx for the duration of the options.  Therefore, with effect from 31 March 2023, RemNOx will hold the voting rights for 30,060,000 Ordinary Shares, equivalent to 29.78% of the total voting rights of SulNOx.

A number of the shareholders entering into the Option Agreements have notifiable holdings under the Disclosure Guidance & Transparency Rules and are Significant Shareholders under the AQSE rules. 

Significant Shareholder Ordinary Shares Held % of Ordinary Shares Held Ordinary Shares Under the Option Agreements % of Ordinary Shares Under the Option Agreements
Stephen Bamford 8,564,200 8.48% 6,000,000 5.94%
James Redman Jr. 7,459,200 7.39% 7,000,000 6.93%
Richard Leggatt 7,307,500 7.24% 7,000,000 6.93%
Gary Bostock 4,173,258 4.13% 1,600,000 1.59%

Sungold Escrow Nominees Ltd ("Sungold"), which holds 96% of the ordinary share capital of RemNOx, has a contract with Leslie Templeton, Chairman of RemNOx, where she holds control of the voting rights of those RemNOx shares, and thus indirectly, RemNOx's holding in SulNOx, and the voting rights transferred to RemNOx under the Option Agreemnets (the "Contract").  The Contract is conditional on certain payments and deliverables being made at certain times, with full ownership of the current Sungold holding in RemNOx transferring to Ms Templeton in tranches.  In the event of default on the payment obligations under the Contract, the voting rights in RemNOx on those shares that have not transferred to Ms Templeton will revert to Sungold.  Sungold is controlled by Angela Bravo.  Under the Option Agreements, the option holders also have option rights to acquire shares in another private company controlled by Sungold.

- Ends -

For further information please contact:

SulNOx Group plc

Steven Cowin, CFO
[email protected]
Allenby Capital Limited

(AQSE Corporate Adviser)

Nick Harriss / John Depasquale
Tel: 020 3328 5656

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NEXFIFETSDISIIV

Talk to a Data Expert

Have a question? We'll get back to you promptly.